[The Role of ME/CFS Phenotype in Outpatient Post-COVID Rehabilitation].
Kaiserseder, Moritz, Prüfer, Ferdinand, Untersmayer-Elsenhuber, Eva et al. · Pneumologie (Stuttgart, Germany) · 2026 · DOI
Quick Summary
This study looked at 216 people recovering from COVID-19 in rehabilitation programs to see how many had ME/CFS—a condition with severe fatigue and worsening after physical activity. The researchers found that about 7% of these patients met the criteria for ME/CFS. These patients were typically younger, mostly women, and experienced much more severe fatigue that didn't improve with rehabilitation compared to other COVID-19 patients.
Why It Matters
This study addresses a critical clinical gap by quantifying ME/CFS prevalence in post-COVID rehabilitation settings and demonstrating that a significant subset of PCS patients exhibit ME/CFS characteristics that may require fundamentally different rehabilitation approaches. Understanding ME/CFS presentation within PCS populations is essential for clinicians to identify and appropriately manage these patients, as standard rehabilitation may be ineffective or harmful due to post-exertional malaise.
Observed Findings
Approximately 7% (15/216) of PCS rehabilitation outpatients met Canadian Consensus Criteria for ME/CFS.
ME/CFS phenotype patients had significantly higher baseline fatigue severity (FAS 35.8±6.4 vs. 27.8±8.6) with minimal improvement over rehabilitation (Δ +1.3±4.5 vs. Δ -5.1±6.2).
ME/CFS phenotype patients were significantly younger (40.6±10.7 vs. 47.7 years) and predominantly female (93% vs. 57%).
Baseline 6-minute walk distance was lower in ME/CFS patients (479 m vs. 540 m), though both groups showed similar improvement trajectories over time.
Inferred Conclusions
A distinct ME/CFS phenotype exists within PCS rehabilitation populations, characterized by severe persistent fatigue and attenuated functional gains despite rehabilitation.
Fatigue Assessment Scale (FAS) may serve as a practical screening tool for identifying ME/CFS among PCS patients, though formal diagnosis via Canadian Consensus Criteria remains essential.
Tailored rehabilitation strategies distinct from standard PCS protocols may be necessary for patients meeting ME/CFS criteria.
Remaining Questions
What rehabilitation interventions, if any, are safe and effective for PCS patients with ME/CFS phenotype, given their attenuated gains on standard programs?
Do PCS patients with ME/CFS represent a distinct disease entity or a severe expression of PCS on a continuum, and what are the underlying biological mechanisms?
What This Study Does Not Prove
This study does not establish causality or determine whether COVID-19 causes ME/CFS or if PCS and ME/CFS are distinct or overlapping conditions. The small sample size of the ME/CFS phenotype group (n=15) limits generalizability. The retrospective design and cross-sectional analysis cannot determine long-term outcomes or identify which rehabilitation factors may be beneficial or harmful for ME/CFS patients.
Can earlier identification of ME/CFS characteristics during acute COVID-19 recovery predict which patients will require alternative rehabilitation approaches?
How do long-term outcomes (beyond 6 months) differ between ME/CFS and non-ME/CFS PCS phenotypes, and what factors predict recovery or persistent disability?